iBio (IBIO) Return on Assets [ROA] (2009 - 2026)
iBio's Return on Assets [ROA] came in at -35.73% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 51.18 percentage points from -86.91% a year earlier and up 1.02 percentage points from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Return on Assets [ROA] was -54.04%, up 16.75 percentage points from FY2025.
- Return on Assets [ROA] has increased in each of the last three fiscal years, though with a five-year change of -34.79 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Assets [ROA] was -70.79% in FY2025 (+0.43 pp), -71.22% in FY2024 (+21.24 pp), -92.47% in FY2023 (-51.63 pp) and -40.84% in FY2022 (-21.58 pp).
- The fiscal Q4 2026 figure represents the highest quarterly Return on Assets [ROA] since fiscal Q3 2022.
- Year-over-year, Return on Assets [ROA] has increased for four consecutive quarters, with an average year-over-year change of +21.34 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q3 2024 (a gain of 103.06 percentage points), and the weakest in fiscal Q3 2023 (a drop of 130.69 percentage points).
- Business Quant data shows IBIO's Return on Assets [ROA] at -36.75% (Q3 2026), -38.49% (Q2 2026) and -46.05% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | -8,155.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -8,155.43% |
| Jun 30, 2026 | -6,231.46% |
| Mar 31, 2026 | -7,664.26% |
| Dec 31, 2025 | -8,952.29% |
| Sep 30, 2025 | -13,165.53% |
| Jun 30, 2025 | -18,933.92% |
| Mar 31, 2025 | -141,608.31% |
| Dec 31, 2024 | -125,011.50% |
| Sep 30, 2024 | -108,505.96% |
| Jun 30, 2024 | -63,145.22% |
| Mar 31, 2024 | -154,362.65% |
| Dec 31, 2023 | -181,233.68% |
| Sep 30, 2023 | -164,790.81% |
| Jun 30, 2023 | -151,904.95% |
| Mar 31, 2023 | -158.09% |
| Dec 31, 2022 | -118.99% |
| Sep 30, 2022 | -64.68% |
| Jun 30, 2022 | -46.84% |
| Mar 31, 2022 | -27.41% |
| Dec 31, 2021 | -21.03% |
API Access
iBio Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();